The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1268
August 27, 2007
View Complete Issue         Table of Contents 2019 
Low-Dose Transdermal Estrogens
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Low-Dose Transdermal Estrogens
August 27, 2007 (Issue: 1268)
Three low-dose transdermal estrogens were recently approved by the FDA for treatment of menopausal vasomotor symptoms. Elestrin and Divigel are transdermal estradiol gels and Evamist is an estradiol spray. Elestrin has been marketed in Europe since...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Low-Dose Transdermal Estrogens
Article code: 1268b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.